Doyle ME, and Egan JM
Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation
Key takeaways Wegovy is a glucagon-like peptide-1 (GLP-1) agonist available in a weekly injection or daily tablet
Despite promising data, TA1 remains experimental for autoimmune conditions
Adverse events that were reported in more than one patient in the treated groups were nausea (n = 2 in the tesamorelin 2 mg group, 11%), diarrhea (n = 2 in the tesamorelin 1 mg group, 11%), generalized weakness (n = 2 in the tesamorelin 1 mg group, 11%), fatigue (n = 2 in the tesamorelin 2 mg group, 11%), headache (n = 2 in the tesamorelin 2 mg group, 11%), upper respiratory tract infection (n = 2 in the tesamorelin 2 mg group, 11%), and light-headedness (n = 2 in the tesamorelin 1 mg group, 11%)
The pore may also provide additional substrate discrimination
